Rebamipide (OPC-12759) in the Treatment of Dry Eye: A Randomized, Double-Masked, Multicenter, Placebo-Controlled Phase II Study
Authors:
- Shigeru KinoshitaSKShigeru Kinoshita
- Saki AwamuraSASaki Awamura
- Kazuhide OshidenKOKazuhide Oshiden
- Norihiro NakamichiNNNorihiro Nakamichi
- Hiroyuki SuzukiHSHiroyuki Suzuki
- Norihiko YokoiNYNorihiko Yokoi
- 1 December 2012
- journal article
- research article
- Published by Elsevier in Ophthalmology
- Vol. 119 (12) , 2471-2478
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- A comparative clinical trial of the efficacy of two different aqueous solutions of cyclosporine for the treatment of moderate-to-severe dry eye syndromeBritish Journal of Ophthalmology, 2010
- Impact of dry eye disease and treatment on quality of lifeCurrent Opinion in Ophthalmology, 2010
- Ophthalmologist Perceptions Regarding Treatment of Moderate-to-Severe Dry Eye: Results of a Physician SurveyEye & Contact Lens: Science & Clinical Practice, 2010
- Rebamipide, a Cytoprotective Drug, Increases Gastric Mucus Secretion in Human: Evaluations with Endoscopic Gastrin TestDigestive Diseases and Sciences, 2008
- Dry eyes: etiology and managementCurrent Opinion in Ophthalmology, 2008
- The Ocular Surface: The Challenge to Enable and Protect VisionInvestigative Ophthalmology & Visual Science, 2007
- Impact of Dry Eye Syndrome on Vision-Related Quality of LifeAmerican Journal of Ophthalmology, 2007
- Tear Film, Contact Lens, and Patient-Related Factors Associated with Contact Lens–Related Dry EyeInvestigative Ophthalmology & Visual Science, 2006
- The Economic Burden of Dry EyeCornea, 2004
- Ocular mucins: Purification, metabolism and functionsProgress in Retinal and Eye Research, 1997